Oncology v 2
-
Upload
samuel-yip -
Category
Documents
-
view
220 -
download
3
description
Transcript of Oncology v 2
![Page 1: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/1.jpg)
ONCOLOGY
![Page 2: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/2.jpg)
Wh
at Is Can
cer?
![Page 3: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/3.jpg)
CANCER DIAGNOSIS
• The term “Cancer” has been use todescribe over 100 different diseasescharacterized by uncontrolled cellgrowth
![Page 4: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/4.jpg)
WARNINGS SIGNS
• Weight loss
• Persistent Fever
• Fatigue
• Sores
• Bowel patterns
• Pain
• Indigestion
• Lump
• Unusual bleeding
![Page 5: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/5.jpg)
Different Kinds of Cancer
Some commoncarcinomas:
Lung
Breast (women)
Colon
BladderProstate (men)
Leukemias:Bloodstream
Lymphomas:Lymph nodes
Some commonsarcomas:Fat
Bone
Muscle
Artwork by Jeanne Kelly. © 2004.
![Page 6: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/6.jpg)
Naming Cancers
Cancer Prefixes Point to LocationPrefix Meaning
adeno-
chondro-
erythro-
hemangio-
hepato-
lipo-
lympho-
melano-
myelo-
myo-
osteo-
gland -
cartilage -
red blood cell
blood vessels
liver -
fat-
lymphocyte
pigment cell
bone marrow
muscle -
bone -
![Page 7: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/7.jpg)
Loss of Normal Growth Control
Normalcell division
Cell Suicide or Apoptosis
Cell damage-no repair
Cancercell division
First Secondmutation mutation
Third Fourth ormutation later mutation
Uncontrolled growth
Art
wor
k by
Jea
nne
Kel
ly. ©
200
4.
![Page 8: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/8.jpg)
Malignant versus Benign Tumors
Benign (not cancer)tumor cells growonly locally and cannotspread by invasion ormetastasis
Malignant (cancer)cells invadeneighboring tissues,enter blood vessels,and metastasize todifferent sites
___ Jjaa
Time
Art
wor
k by
Jea
nne
Kel
ly. ©
200
4.
![Page 9: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/9.jpg)
Why Cancer Is Potentially Dangerous
Brain
LiverMelanoma
(initial tumor)
Artwork by Jeanne Kelly. © 2004.
Melanomacells travelthroughbloodstream
![Page 10: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/10.jpg)
![Page 11: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/11.jpg)
PROPERTIES OF CANCER CELLS
* Growth without “go” (positive) signals
* Failure to respond to “stop” (negative) signals
* Evasion of programmed cell death (apoptosis)
* Unlimited cell division
* Sustained angiogenesis (stimulation of blood
vessel growth)
* Tissue invasion and metastasis
![Page 12: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/12.jpg)
GROWTH WITHOUT “GO”(POSITIVE) SIGNALS
* Growth factors
* Oncogene
![Page 13: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/13.jpg)
FAILURE TO RESPOND TO “STOP”(NEGATIVE) SIGNALS
• Contact inhibition
Tumour suppressor genes
![Page 14: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/14.jpg)
EVASION OF PROGRAMMED CELLDEATH (APOPTOSIS)
• Death signals
p53
![Page 15: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/15.jpg)
UNLIMITED CELL DIVISION
* Telomeres
Telomerases
![Page 16: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/16.jpg)
SUSTAINED ANGIOGENESIS(STIMULATION OF BLOOD VESSEL
GROWTH)
• VEGF (Vascular Endothelial GrowthFactors)
Nutrient, oxygen
![Page 17: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/17.jpg)
TISSUE INVASION AND METASTASIS
* 90% of cell death due to single cellmutation
Migration
![Page 18: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/18.jpg)
COMMON DIAGNOSTIC TESTS
• Blood test
• Imaging test
• Biopsy
• Cancer Staging
![Page 19: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/19.jpg)
BLOOD TESTS
• Tumour markers - protein that arefound to be elevated in certaincancer
Use to check for treatment response
![Page 20: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/20.jpg)
BLOOD TESTS
* Examples includes:
* CA125 for Ovarian Cancer (protein produced
when abdominal tissues are inflamed)
* PSA also known as Prostate specific antigen for
Prostate cancer(protein produce by prostate
cells, when too many will increase)
* AFP also known as alpha fetoprotein for liver
cancer (protein produce by liver tumours but
also elevate in hepatitis)
![Page 21: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/21.jpg)
IMAGING
• X rays, ultrasound to create image of
internal structures
• CT scan (multiple X rays to form 3D
image)
• MRI also known as magnetic resonance
imaging use magnetic field to create
image
![Page 22: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/22.jpg)
BIOPSY
• Removal of small piece of tissue from
patient
* Expert to look at microscopic images,
check for tumour markers or DNA
mutations
![Page 23: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/23.jpg)
CANCER STAGING
* After diagnosis have been made, staging
perform to determine the extend of the disease
progression and evaluate the best treatments
* T: 1-4 For size of tumour(Larger number indicate
larger tumours and spread
* N 0-2 For presence of tumour in lymph nodes
(Larger number indicate spread)
•Ml given to metastases (0 indicate not
spreading)
![Page 24: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/24.jpg)
Cancer Detection and Diagnosis
Art
wor
k by
Jea
nne
Kel
ly. ©
200
4.
![Page 25: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/25.jpg)
Early Cancer May Not Have Any Symptoms
Art
wor
k by
Jea
nne
Kel
ly. ©
200
4.
![Page 26: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/26.jpg)
Cervical Cancer Screening
NormalPap smear
AbnormalPap smear
![Page 27: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/27.jpg)
Breast C
ancer Screening
![Page 28: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/28.jpg)
![Page 29: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/29.jpg)
Colon Cancer Screening
Art
wor
k by
Jea
nne
Kel
ly. ©
200
4.
![Page 30: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/30.jpg)
Art
wor
k by
Jea
nne
Kel
ly. ©
200
4.
Biopsy
or blood sample Genomic profile
![Page 31: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/31.jpg)
Microscopic Appearance of Cancer Cells
Normal Cancer
Large number of irregularlys^aPec* div'd'ng cells
a Large, variably shaped nuclei
a Small cytoplasmic volumerelative to nuclei
Variation in cell size and shape
Loss of normal specializedcell features
^ Disorganized arrangement
Poorly defined tumor boundary
2004
.
![Page 32: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/32.jpg)
Tumor Grading
100%
General Relationship BetweenTumor Grade and Prognosis
PatientSurvival
Rate
Low grade
High grade
Years
![Page 33: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/33.jpg)
Tumor Staging
100%
50%
Five-Year Survival Rates forPatients with Melanoma (by stage)
I II III
Stage at Time of Initial Diagnosis
Art
wor
k by
Jea
nne
Kel
ly. ©
200
4.
![Page 34: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/34.jpg)
What Causes Cancer?
Some viruses or bacteria
Some chemicals Radiation
Artwork by Jeanne Kelly. © 2004.
![Page 35: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/35.jpg)
ROLES OF DNA DAMAGE ANDMUTATION
• Radiation
• Chemicals
• Environmental toxins
Others
![Page 36: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/36.jpg)
RADIATION
• Examples such as: X rays, CT scan, UV,
radon (radioactive gas)
* Production of Free radicals - atoms with
unpaired electrons
* Antitoxin such as some vitamins
![Page 37: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/37.jpg)
CHEMICALS AND ENVIRONMENTAL
TOXINS
• Chemicals such as mustard gas,hair dyes, chemotherapy drugs
• Environmental toxins such as tarfrom cigarette, coal etc
![Page 38: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/38.jpg)
OTHERS
• Virus such as oncoviruses examples Epstein-Barr virus(EBV), Human papillomavirus (HPV), mouse mammarytumour virus (MMTV)
• Specific virus to cancer types
• Hepatitis B,C (Liver Cancer)
• HPV (Cervical Cancer)
• EBV (Lymphatic Cancer)• Kaposi sarcoma herpes virus (Kaposi sarcoma skin
cancer)
• Human T lymphotrophic Virus 1 (T cell leukemia)
![Page 39: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/39.jpg)
Viruses
Virus insertsand changesgenes forcell growth
Cancer-linked virus
Art
wor
k by
Jea
nne
Kel
ly. ©
200
4.
![Page 40: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/40.jpg)
Examples of Human Cancer Viruses
Some Viruses Associated with Human Cancers
Virus Type of Cancer
Epstein-Barr virus Burkitt’s lymphoma
Human papillomavirus Cervical cancer
Hepatitis B virus Liver cancer
Human T-celllymphotrophic virus
Adult T-cell leukemia
Kaposi’s sarcoma-associated herpesvirus
Kaposi’s sarcoma
Art
wor
k by
Jea
nne
Kel
ly. ©
200
4.
![Page 41: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/41.jpg)
AIDS and Kaposi’s Sarcoma
Art
wor
k by
Jea
nne
Kel
ly. ©
200
4.
![Page 42: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/42.jpg)
Bacteria and Stomach Cancer
Artwork bv can c Koiiy. 2004 Patient’s tissue H. pylorisample
![Page 43: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/43.jpg)
Heredity and Cancer
■ Inherited factor(s)■ Other factor(s)
Art
wor
k by
Jea
nne
Kel
ly. ©
200
4.
![Page 44: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/44.jpg)
Heredity Can Affect Many Types of Cancer
Inherited Conditions That Increase Risk for Cancer
Name of Condition Type of Cancer
Hereditary retinoblastoma Retinoblastoma
Xeroderma pigmentosum Skin
Wilms’ tumor KidneyLi-Fraumeni syndrome Sarcomas, brain, breast,
leukemia
Familial adenomatouspolyposis
Colon, rectum
Paget’s disease of bone Bone
Fanconi’s aplastic anemia Leukemia, liver, skin
Art
wor
k by
Jea
nne
Kel
ly. ©
200
4.
![Page 45: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/45.jpg)
Genetic Testing
![Page 46: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/46.jpg)
Cancer Risk and Aging
Number ofCancer Cases(per 100,000
people)
Cancer Risk and Aging400
300
200
100
0 20 40 60 80
Age of Person (in years)
![Page 47: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/47.jpg)
DNA Mutation
Normal gene
C G A A C T
Single base change
Deletions
![Page 48: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/48.jpg)
Normal cell
Cancer cell
Oncogenes
Mutated/damaged oncogene
Art
wor
k by
Jea
nne
Kel
ly. ©
200
4.
![Page 49: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/49.jpg)
Proto-Oncogenes and Normal Cell Growth
Normal Growth-Control Pathway
Growth factor
Receptor
Cell nucleus
0 Signaling enzymes
Transcriptionfactors
DNA
ell t
Cell proliferatio
![Page 50: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/50.jpg)
Oncogenes areMutant Forms of Proto-Oncogenes
Inactive growth factor receptor Inactive intracellularsignaling protein
Signaling protein from active oncogene
Cell proliferation driven byinternal oncogene signaling
Art
wor
k by
Jea
nne
Kel
ly. ©
200
4.
![Page 51: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/51.jpg)
Normalgenes
preventcancer
Remove or inactivate tumorsuppressor genes
Damage toboth genesleads tocancer
Normal cell
![Page 52: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/52.jpg)
Tumor Suppressor GenesAct Like a Brake Pedal
Growth factor
Receptor
Cell nucleus
Tumor Suppressor
Art
wor
k by
Jea
nne
Kel
ly. ©
200
4.
![Page 53: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/53.jpg)
p53 Tumor Suppressor ProteinTriggers Cell Suicide
Normal cell Excessive DNA damage Cell suicide(Apoptosis)
Art
wor
k by
Jea
nne
Kel
ly. ©
200
4.
![Page 54: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/54.jpg)
Base pairmismatch
![Page 55: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/55.jpg)
Cancer Tends to Involve Multiple Mutations
Benign tumor cells Malignant cells invadegrow only locally and neighboring tissues, entercannot spread by blood vessels, and metastasize
to different sitesinvasion or metastasis
Time
Mutation Cells Mutations Proto-oncogenes More mutations,inactivates proliferate inactivate mutate to oncogenes more geneticsuppressor DNA repair instability,gene genes metastatic
disease
Art
wor
k by
Jea
nne
Kel
ly. ©
200
4.
![Page 56: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/56.jpg)
Mutations and Cancer
Genes Implicated in CancerThe prime suspects But
Mutations in: Other mutations also occur in:
Oncogenes Cell death genes
■ Tumor suppressor genes Cell signaling genes
■ DNA repair genes Cell cycle checkpoint genes
Cellular senescence genes
■ Cellular differentiation genes
■ Metastasis/invasion genes
Carcinogen-activating genes-deactivating genes A
rtw
ork
by J
eann
e K
elly
. © 2
004.
![Page 57: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/57.jpg)
Cancer Tends toCorrupt Surrounding Environment
Blood vessel Cytokines!
Growth factors = proliferationInvasive
Matrix
Fibroblasts,adipocytes
Cytokines, proteases = migration & invasion
Art
wor
k by
Jea
nne
Kel
ly. ©
200
4.
![Page 58: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/58.jpg)
TREATMENTS
* Surgery
* Radiation
* Chemotherapy
* Others
![Page 59: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/59.jpg)
SURGERY
• Removal of solid cancerous tumour as
much as possible
* Exception include blood cancer such as
leukaemia
![Page 60: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/60.jpg)
RADIATION
* Use of high energy waves to kill or inhibit cell
division
* External beam or seed radioactive within the
tumour
* Trigger apoptosis due to DNA damage but affects
normal cells
![Page 61: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/61.jpg)
CHEMOTHERAPY
* Use of drugs to treat cancer
* Side effects include hair loss, nausea
* Damage DNA
* Interfere with DNA replication
* Interfere with cell division
![Page 62: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/62.jpg)
CHEMOTHERAPY
* Cisplatin (Platinol) for DNA damage
* Doxorubicin (Adriamycin) for DNA
damage
* 5 fluorouracil (Efudex, Adrucil) inhibit
DNA replication* Paclitaxel (Taxol) inhibit mitosis
* Vinblastine (Velban) inhibit mitosis
![Page 63: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/63.jpg)
OTHERS
• Bone marrow Transplantation
• Targeted Therapies
• Tumour Vaccines
• Gene Therapy
![Page 64: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/64.jpg)
BONE MARROW TRANSPLANTATION
• Leukaemia
• Lymphoma
• Stem cells are often damage after
chemotherapy and radiation
• Taken before patient and put back after
treatment
![Page 65: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/65.jpg)
TARGETED THERAPIES
• Pharmacogenomics
• Specialized treatment based onhuman genetics
• Fewer side effects
![Page 66: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/66.jpg)
TUMOUR VACCINE
• Prevent infection example from oncovirus
* Gardasil for cervical cancer as it target
HPV
![Page 67: Oncology v 2](https://reader035.fdocuments.net/reader035/viewer/2022062712/563db9ba550346aa9a9f5b8b/html5/thumbnails/67.jpg)
GENE THERAPY
* Introduction of DNA to allow protein to be
made to overcome disease• P53
Clinical Trails